Axim Biotechnologies Inc (OTCQB:AXIM)
| 0.6249 Delayed Data As of Sep 25 |  -0.0001 / -0.02%Today’s Change | 0.10 Today|||52-Week Range 1.44 | +71.21% Year-to-Date |
Latest AXIM News | Press Releases
| AXIM Bio seeks emergency use of COVID-19 rapid diagnostic test Sep 16 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 0.63 |
| Today’s open | 0.68 |
| Day’s range | 0.60 - 0.68 |
| Volume | 92,047 |
| Average volume (3 months) | 802,124 |
| Market cap | $73.9M |
Data as of 09/25/2020
Growth & Valuation
| Earnings growth (last year) | +11.70% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +308.70% |
| P/E ratio | -- |
| Price/Sales | 28.28 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $799.5K |
| Annual profit (last year) | -$6.4M |
| Net profit margin | -806.47% |
Profile
Sector Industrial Services |
Industry Environmental Services |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
Chart unavailable
